Australia markets closed

PharmAust Limited (PAA.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.3750+0.0350 (+10.29%)
At close: 04:10PM AEDT
Full screen
Previous close0.3400
Open0.3450
Bid0.3700 x 0
Ask0.3750 x 0
Day's range0.3450 - 0.3800
52-week range0.0655 - 0.5350
Volume1,474,936
Avg. volume1,471,079
Market cap147.705M
Beta (5Y monthly)1.25
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS

    PharmAust Limited (ASX: PAA & PAAOA) ("PharmAust" or "the Company"), a clinical-stage biotechnology company, is pleased to announce that it has met its primary safety and tolerability endpoints with monepantel (MPL) and, importantly, demonstrated a positive signal of potential efficacy. Rates of disease progression in patients with Motor Neurone Disease (MND) / Amyotrophic Lateral Sclerosis (ALS) measured by changes in ALSFRS-R may be slowed by 58% for Cohort 2, when compared to an external cont